Concepedia

Real-world Assessment of 2,879 COVID-19 Patients Treated with Monoclonal Antibody Therapy: A Propensity Score-Matched Cohort Study

Megan H. Cooper, Paul Christensen, Eric Salazar, Katherine K. Perez, Edward A. Graviss, Duc T. Nguyen, James M. Musser, Howard J. Huang, Michael G. Liebl

Open Forum Infectious Diseases · 2021 · 25 citations · 20 references

DOI Full text

Open access

Abstract

Treatment with bamlanivimab, bamlanivimab-etesevimab, or casirivimab-imdevimab significantly decreased the number of patients who progressed to severe COVID-19 disease and required hospitalization.

References

20

A Proportional Hazards Model for the Subdistribution of a Competing Risk

Jason P. Fine · Journal of the American Statistical Association · 1999 · 13.2K citations

Prognosis, Rare Event Estimation, Risk Metric +21

Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity‐score matched samples

Peter C. Austin · Statistics in Medicine · 2009 · 6.1K citations · Full text

Propensity Score, Health Policy, Matching Technique +14

Estimates of the severity of coronavirus disease 2019: a model-based analysis

Robert Verity, Lucy Okell, Ilaria Dorigatti et al. · The Lancet Infectious Diseases · 2020 · 4.1K citations · Full text

Effectiveness of convalescent plasma therapy in severe COVID-19 patients

Kai Duan, Bende Liu, Cesheng Li et al. · Proceedings of the National Academy of Sciences · 2020 · 2K citations · Full text

REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19

David M. Weinreich, Sumathi Sivapalasingam, Thomas Norton et al. · New England Journal of Medicine · 2020 · 1.8K citations · Full text